This regulation defines the purpose, the operational processes, and the organization of the registry BEAT-SHOCK (Basel Evaluation of Acute Therapy in cardiogenic SHOCK). It describes the requirements for collecting, storing, processing, managing and sharing health-related registry data.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
* Patients admitted with cardiogenic shock to the University hospital Basel (diagnosis at the time of admission) or development of cardiogenic shock during the hospital stay
* Age ≥18 years
* Provision of written ICF
* Clinical diagnosis of cardiogenic shock.
* impaired organ perfusion due to primary cardiac dysfunction,
* persistent systolic blood pressure (SBP) \<90 mmHg for ≥30 minutes, or the need for vasopressors, inotropes, or mechanical circulatory support (MCS) to maintain adequate perfusion and
* evidence of systemic hypoperfusion with arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l and ≥1 of the following:
* Cold or clammy extremities
* Altered mental status
* Reduced urine output
* Signs of volume overload or congestion (on clinical exam, imaging, or invasive monitoring)
* Patients with normotensive cardiogenic shock (SBP ≥90 mmHg without vasopressors or MCS) may also be included if clear signs of hypoperfusion (arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l) and cardiac dysfunction are present and alternative causes are excluded
Exclusion criteria:
* Age \<18 years
* Refusal to provide informed consent by the patient or their legally authorized representative
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this is a registry study that's observing and recording what happens to patients with cardiogenic shock rather than testing a new treatment, does joining it change anything about the actual care I would receive, or would my treatment decisions stay exactly the same?
2The registry is tracking in-hospital all-cause mortality as its main outcome — what does my doctor think that means for understanding my own prognosis, and how does my specific cause of cardiogenic shock (such as a heart attack, heart failure, or another cause) affect what to expect?
3Because this is a registry and not a Phase 1, 2, or 3 drug or device trial, are there any additional procedures, data collections, or follow-up visits involved that I or my family would need to participate in while I'm hospitalized?
4Given that the registry covers several different causes of cardiogenic shock, including heart attacks, fulminant myocarditis, and post-surgery cases, would my doctor say the data being collected is relevant to my specific situation, and how might it help future patients like me?
5Are there any standard treatments or intervention trials for my type of cardiogenic shock that my doctor thinks I should also be considering alongside or instead of participating in this registry?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
In-Hospital all-cause mortality occurring before discharge from the participating study centre